These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13913645)

  • 1. Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy.
    SKIPPER HE; SCHABEL FM; TRADER MW; THOMSON JR
    Cancer Res; 1961 Oct; 21():1154-64. PubMed ID: 13913645
    [No Abstract]   [Full Text] [Related]  

  • 2. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA.
    SKIPPER HE; SCHABEL FM; WILCOX WS
    Cancer Chemother Rep; 1965 Apr; 45():5-28. PubMed ID: 14321918
    [No Abstract]   [Full Text] [Related]  

  • 3. The stathmokinetic effect of vincaleukoblastine on normal bone marrow and leukemic cells.
    CARDINALI G; CARDINALI G; BLAIR J
    Cancer Res; 1961 Dec; 21():1542-4. PubMed ID: 13876510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Grafts of bone marrow after total irradiation of leukemic mice followed by the administration of an antimitotic product].
    MATHE G; AMIEL JL; NIEMETZ JL
    Bull World Health Organ; 1962; 26(5):692-5. PubMed ID: 14471073
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.
    SCHRECKER AW; MEAD JA; LYNCH MR; VENDITTI JM; GOLDIN A
    Cancer Res; 1960 Nov; 20():1457-61. PubMed ID: 13748581
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. II.
    GOLDIN A; VENDITTI JM; KLINE I; MANTEL N
    Cancer Res; 1960 Jun; 20(5)Pt 2():382-469. PubMed ID: 13850662
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. V.
    GOLDIN A; VENDITTI JM; KLINE I
    Cancer Res; 1962 May; (Suppl)():157-220. PubMed ID: 13899778
    [No Abstract]   [Full Text] [Related]  

  • 8. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

  • 9. A manual on quantitative drug evaluation in experimental tumor systems.
    GOLDIN A; VENDITTI JM
    Cancer Chemother Rep; 1962 Apr; 17():145-78. PubMed ID: 13899780
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE EFFECT OF D,L-GLYCERALDEHYDE AND ACROLEIN ON LEUKEMIC LEUKOCYTES OF THE EXPERIMENTAL HEMOBLASTOSES L 14 AKR AND LAH VUFB IN VITRO].
    MOTYCKA K; LACKO L
    Z Krebsforsch; 1965 Feb; 66():491-5. PubMed ID: 14263010
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential metabolic responses of susceptible and resistant mouse leukemia cells to 8-azaguanine.
    BURK D; LASZLO J; HUNTER J; WIGHT K; WOODS M
    J Natl Cancer Inst; 1960 Jan; 24():57-76. PubMed ID: 13806121
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced leukemia as a tool for chemotherapeutic studies.
    GOLDIN A; VEDITTI JM; HUMPHREYS SR; SHUSTER L; DARROW RA; MANTEL N
    Acta Unio Int Contra Cancrum; 1960; 16():642-50. PubMed ID: 13850661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].
    MATHE G; AMIEL JL; NIEMETZ J
    C R Hebd Seances Acad Sci; 1962 May; 254():3603-5. PubMed ID: 14471072
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic activity of basic bisepoxides in murine leukemia and other transplantable mouse neoplasms.
    JOHNSON IS; WRIGHT HF
    Acta Unio Int Contra Cancrum; 1960; 16():676-81. PubMed ID: 14407466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of certain benzoquinone-ethyleneimino derivatives on experiemental mouse leukemia].
    SOBESLAVSKY C; SOCHMAN J; MOTYCKA K
    Neoplasma; 1959; 6():268-74. PubMed ID: 13832381
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of epoxypropyl piperazine derivatives on a spectrum of transplanted mouse leukemias.
    BURCHENAL JH; HOLMBERG E; WIEGAND L; HEMPHILL S; KRAKOFF IH
    Acta Unio Int Contra Cancrum; 1960; 16():556-60. PubMed ID: 13806001
    [No Abstract]   [Full Text] [Related]  

  • 17. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
    SKIPPER HE; SCHABEL FM; WILCOX WS
    Cancer Chemother Rep; 1964 Feb; 35():1-111. PubMed ID: 14117037
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
    KOSHIURA R; KOSHIMURA S; BANDO Y
    Gan; 1964 Oct; 55():433-41. PubMed ID: 14247592
    [No Abstract]   [Full Text] [Related]  

  • 19. Method of biological assay of compounds effective in the treatment of IRC 741 leukemia in Fischer rats.
    ARMAGHAN V
    J Natl Cancer Inst; 1960 Jul; 25():125-31. PubMed ID: 13794263
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a leukaemia resistant to cyclophosphamide ('Cytoxan').
    LANE M; YANCEY ST
    Nature; 1960 Nov; 188():756-7. PubMed ID: 13758721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.